GeneReach Biotechnology Corp
TPEX:4171
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GeneReach Biotechnology Corp
TPEX:4171
|
TW |
|
Pure Foods Tasmania Ltd
ASX:PFT
|
AU |
|
P
|
Pinnacle Silver and Gold Corp
XTSX:PINN
|
CA |
|
W
|
Wuxi Acryl Technology Co Ltd
SSE:603722
|
CN |
|
Lexibook Linguistic Electronic System SA
PAR:ALLEX
|
FR |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
|
Australian Oil & Gas Corp
OTC:AOGC
|
AU |
|
Askari Metals Ltd
F:7ZG
|
AU |
|
E
|
E3 Metals Corp
OTC:EEMMF
|
CA |
|
City Chic Collective Ltd
OTC:CCCHF
|
AU |
|
T
|
Tissue Repair Ltd
ASX:TRP
|
AU |
|
I
|
Ipopema Securities SA
WSE:IPE
|
PL |
|
Kenon Holdings Ltd
NYSE:KEN
|
SG |
|
F
|
Far East Wind Power Corp
OTC:FEWP
|
US |
|
A
|
Alfonsino SpA
MIL:ALF
|
IT |
|
Montagne et Neige Developpement SA
PAR:ALMND
|
FR |
|
I
|
IMBiologics Corp
KOSDAQ:493280
|
KR |
|
N
|
Norwegian Energy Company ASA
F:CJ1
|
NO |
|
O
|
Otsuka Pakistan Ltd
KAR:OTSU
|
PK |
|
T
|
Tolu Minerals Ltd
ASX:TOK
|
AU |
|
I
|
Initiator Pharma A/S
STO:INIT
|
DK |
|
Adamant DRI Processing and Minerals Group
OTC:ADMG
|
CN |
Dividends
Dividend Yield
GeneReach Biotechnology Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
GeneReach Biotechnology Corp
Payout Ratio
GeneReach Biotechnology Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for GeneReach Biotechnology Corp is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
GeneReach Biotechnology Corp
| Average Annual Return | -18.93% |
| Standard Deviation of Annual Returns | 10.96% |
| Max Drawdown | -85% |
| Market Capitalization | 968.4m TWD |
| Shares Outstanding | 58 060 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
GeneReach Biotechnology Corp's latest stock split occurred on Jul 28, 2023
The company executed a 1250-for-1000 stock split, meaning that for every 1000 shares held, investors received 1250 new shares.
Before the split, GeneReach Biotechnology Corp traded at 42.08 per share. Afterward, the share price was about 40.9.
The adjusted shares began trading on Jul 28, 2023. This was stock split number 3 in GeneReach Biotechnology Corp's history, following the previous one in Sep 13, 2022.
